RopesTalk

On this Ropes & Gray podcast, asset management partners Jason Kolman and Jessica Marlin are joined by Daren Moreira, a partner at Eversheds Sutherland, to discuss the NAIC’s updated Statement of Statutory Accounting Principles No. 26 (SSAP 26). They discuss the background of and guidance in SSAP 26, and its potential impact on rated note fund structures.

As popular as the phrase “Do the Right Thing” may be, defining the “Right Thing” can be quite a complex and even controversial exercise. On this episode of There Has to Be a Better Way?, NYU Professor Alison Taylor tackles the question of what it means for a business to do the right thing in today’s world, with multiple—and often conflicting—stakeholder expectations. She challenges some common notions such as “bring your whole self to work” and “courage to speak up” with deeper questions that will get you thinking!

Welcome to the first installment of Ropes & Gray’s new podcast series, Controlling Opinions, which is focused on current trends and developments related to controlled substances that affect the health care and life sciences industries. In this inaugural episode, hear a cross-practice team of Ropes & Gray attorneys—Andrew O’Connor, Josh Oyster, Stephen Warnke, and Beth Weinman—discuss the controlled substances issues that have their attention, including the potential federal rescheduling of marijuana; regulatory and legislative developments related to psychedelic drugs; litigation and enforcement developments involving opioids and ADHD medications; and enforcement trends and investigation best practices for diversion incidents at health care providers.

Tune in to the fourth episode of Ropes & Gray's podcast series, The Data Day, brought to you by the firm’s data, privacy & cybersecurity practice. This series focuses on the day-to-day effects that data has on all of our lives as well as other exciting and interesting legal and regulatory developments in the world of data, and features a range of guests, including clients, regulators and colleagues. On this episode, hosts Fran Faircloth, a partner in Washington, D.C., and Edward Machin, counsel in London, are joined by London partner Rohan Massey, a leader of the firm’s data, privacy & cybersecurity practice, and special guest Sajai Singh, a partner at J. Sagar Associates in Bangalore, to discuss the Digital Personal Data Protection Act, India’s long-awaited comprehensive data protection law. 

On this fifth and final episode of Ropes & Gray’s Recent Trends & Developments in Health Care Joint Ventures podcast series, health care partner Stephanie Webster moderates a discussion with health care partners Brett Friedman and Jenn Romig on two alternative partnership models for health care joint ventures: clinically integrated networks and professional services agreement models. They look at how these two alternatives both compare and differ from a traditional joint venture partnership as well as share their perspective on why health care entities might choose to enter into any one of these arrangements.

This installment of Ropes & Gray’s podcast series Non-binding Guidance focuses on FDA’s recently issued draft guidance, “Communications From Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products – Questions and Answers.” In this episode, hear from Kellie Combs, Josh Oyster, and Sarah Blankstein, industry-leading attorneys from Ropes & Gray’s life sciences regulatory and compliance team, as they delve into FDA’s new draft guidance to discuss key changes, constitutional considerations, and practical implications for the medical products industry.

On this episode of There Has to Be a Better Way?, co-hosts Hui Chen and Zach Coseglia go it alone in a one-to-one talk designed specifically for ethics and compliance professionals. In past episodes, guests have hailed the power of storytelling, and this week, Hui and Zach share personal stories—and learnings—from their decades of experience in the world of corporate ethics and compliance. Topics include: earning a seat at the table through relationship-building and diplomacy; why complication and complexity isn’t always bad, but a lack of clarity is; and why compliance is, and needs to be recognized as, an area of unique expertise. 

On this episode of the R&G Tech Studio, asset management partner Melissa Bender sits down with litigation & enforcement partner Helen Gugel to discuss the evolving regulatory landscape for digital assets, cryptocurrencies, blockchain and related technologies, and potential impacts for clients operating in this space.

On this fourth episode of Ropes & Gray’s Recent Trends & Developments in Health Care Joint Ventures podcast series, health care partner Brett Friedman discusses key regulatory considerations for payor and provider alignment models, including clinically integrated networks and vertical integration transactions, as well as approaches for mitigating risk in markets increasingly scrutinized by federal and state regulators.

This installment of Ropes & Gray’s podcast series Non-binding Guidance focuses on FDA’s proposed rule that would affirm the Agency’s position that laboratory developed tests (“LDTs”) are in vitro diagnostic products regulated as medical devices under the Federal Food, Drug, and Cosmetic Act (“FDCA”). In this episode, hear from Greg Levine, Josh Oyster, and Beth Weinman, industry-leading attorneys from Ropes & Gray’s life sciences regulatory and compliance team based in Washington, D.C., as they discuss FDA’s proposal to phase out the enforcement discretion policy it has historically applied to most LDTs.